Huimin lead Baxter and then Edwards Lifesciences in Japan, Asia and Pacific for nearly 30 years until stepping down from his position as Corporate Vice President in August, 2022. While at Edwards, Huimin led the introduction of new practice-changing therapies and delivered outstanding business results. His particular areas of success include leading large scale and highly diverse cross-functional teams through product development lifecycles from concept to commercialization, obtaining regulatory approvals and reimbursement for new technologies and formulating and executing platform sales strategies to improve revenue in varying markets.

 

While leading Edwards Japan, Huimin was also the founding Chairman of the American Medical Device and Diagnostics Manufacturers’ Association (AMDD), an an industry group that functions as an intermediary to the Japanese Government and related administrative bodies. With the cooperation of the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA), AMDD has been instrumental in the acceleration of the medical device review process in Japan and the elimination of device lag.

 

Prior to joining Baxter in 1993, Huimin was in consulting roles at Booz, Allen, McKinsey and Integrated Strategies, a consulting and venture management firm he co-founded.

 

Before making the leap into the business world in order to have a positive impact on a larger patient population, Huimin was a resident and staff physician in Anesthesiology at Keio University Hospital in Tokyo. In 2006, he was appointed as visiting Associate Professor for Keio's Department of Anesthesiology.

 

Huimin received an MD degree from Kagoshima University and an MBA from the University of Chicago.